US Federal Circuit Refuses To Rehear Arguments In Hatch-Waxman Venue Litigation
Valeant Petition For Full ‘En Banc’ Rehearing Fails
Mylan disputed Valeant's complaint in New Jersey federal court for improper venue, on the basis that Valeant firm had no relevant ties to New Jersey and the only alleged act of infringement – submission of the ANDA – did not occur there.
You may also be interested in...
An appeals court ruling in the US stands to “drastically change” the venue options for brand companies to sue ANDA filers.
Glenmark has moved to bolster its over-the-counter business in the US by acquiring a portfolio of approved generic OTC products from Wockhardt.
The Securities and Exchange Board of India has warned Aurobindo that it did not disclose sufficient information about a US FDA warning letter that it received in connection with its Unit 1 API facility in Hyderabad early this year.